Artificial Intelligence
From Aignostics GmbH: Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s precision oncology development portfolio ...
ORNL: Artificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer. In partnership with the National Cancer Institute, or NCI, researchers from the Department of Energy’s Oak Ridge National...
From Diagnostics World: By Deborah Borfitz March 7, 2024 | Biomedical engineers have a significant role to play in the development and optimization of liquid biopsies to further precision oncology. Although molecular...
CND Biomarker Testing Services Utilizing Groundbreaking NerValence™ System Unveiled at the AD/PD™ 2024 Parkinson's and Alzheimer's Disease Conference SCOTTSDALE, Ariz.., March 5, 2024 /PRNewswire/ -- CND Life Sciences (CND), a...
Nijmegen, Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, announced the introduction of its NephroPath platform. By partnering with Aiosyn,...
The College of American Pathologists (CAP) has updated its evidence-based guideline for analytic validation of immunohistochemical (IHC) assays to provide increased accuracy and consistency in laboratory practices. Many of the...
